Ketoconazole (all routes except local only) updated on 01-29-2025

Table   Graphic     exposition period:

Congenital malformations
Adverse outcome OR 95%CII2k No. casesNo. exposedpublication biasROBE-value
All congenital malformations (majors, minors, majors and minors, or unspecified)1.25 [0.49, 3.18]0%2 studies48,00483not evaluable ROB-
Congenital heart defects3.11 [0.81, 11.97]0%2 studies7,52811not evaluable ROB-
Major congenital malformations1.25 [0.49, 3.18]0%2 studies48,00483not evaluable ROB-
Ano-rectal atresia and stenosis7.63 [0.31, 187.87]-1 study2091not evaluable ROB-
Cleft lip with or without cleft palate1.47 [0.06, 36.00]-1 study1,0861not evaluable ROB-
Craniosynostosis3.56 [0.14, 87.59]-1 study4471not evaluable ROB-
Diaphragmatic hernia5.80 [0.24, 142.60]-1 study2751not evaluable ROB-
Gastroschisis3.50 [0.14, 86.05]-1 study4551not evaluable ROB-
Hypospadias6.16 [0.38, 98.57]-1 study7762not evaluable ROB-
Neural Tube Defects6.37 [0.40, 101.99]-1 study7502not evaluable ROB-

Hide endpoints reported in only one study ...